Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review
Abstract Background The World Health Organization declared on March 11, 2020, that the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has escalated from epidemic into pandemic. As the initial outbreak area, China has taken multiple active measures to deal with the epidemi...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-08-01
|
| Series: | Systematic Reviews |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13643-020-01432-4 |
| _version_ | 1818250320166256640 |
|---|---|
| author | Yuxi Li Juan Li Dongling Zhong Yue Zhang Yonggang Zhang Yan Guo Mike Clarke Rongjiang Jin |
| author_facet | Yuxi Li Juan Li Dongling Zhong Yue Zhang Yonggang Zhang Yan Guo Mike Clarke Rongjiang Jin |
| author_sort | Yuxi Li |
| collection | DOAJ |
| description | Abstract Background The World Health Organization declared on March 11, 2020, that the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has escalated from epidemic into pandemic. As the initial outbreak area, China has taken multiple active measures to deal with the epidemic. Updated versions of diagnosis and treatment guideline for novel coronavirus (COVID-19) patients have been issued, and traditional Chinese herbal medicine has been recommended as a treatment. The objective of this study will be to summarize the recommendations in current clinical practice guidelines about the use of traditional Chinese herbal medicine for COVID-19 patients. We will also evaluate and report on the methodological and reporting quality of these guidelines. Methods In this systematic review, we will search for guidelines, expert consensuses, and policy documents published since December 2019 in electronic databases (e.g., PubMed, EMBASE, and Chinese databases) and on websites of governments or organizations (e.g., The National Guideline Clearinghouse [NGC], Guidelines International Network [GIN], National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network [SIGN], and WHO). Eligible documents will be independently selected, and relevant data will be independently extracted by two reviewers. We will also independently evaluate the methodological quality and reporting quality of the included guidelines, using the Appraisal of Guidelines for REsearch & Evaluation (AGREE) II tool and Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement, respectively. Any discrepancies will be discussed and resolved through discussion among the reviewers. We will use the extracted information to summarize their recommendations for traditional Chinese herbal formulae and Chinese patent medicine for COVID-19 patients and to summarize the strength and quality of these recommendations with reference to the results of AGREE II and RIGHT tools. Discussion This review will summarize the recommendations in current clinical practice guidelines and provide insight into the implementation strategies for traditional Chinese herbal medicine in COVID-19 patients. Systematic review registration PROSPERO CRD42020179205 |
| first_indexed | 2024-12-12T15:50:31Z |
| format | Article |
| id | doaj.art-0df5e6e034744850b4141099839ca951 |
| institution | Directory Open Access Journal |
| issn | 2046-4053 |
| language | English |
| last_indexed | 2024-12-12T15:50:31Z |
| publishDate | 2020-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Systematic Reviews |
| spelling | doaj.art-0df5e6e034744850b4141099839ca9512022-12-22T00:19:37ZengBMCSystematic Reviews2046-40532020-08-01911510.1186/s13643-020-01432-4Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic reviewYuxi Li0Juan Li1Dongling Zhong2Yue Zhang3Yonggang Zhang4Yan Guo5Mike Clarke6Rongjiang Jin7School of Acupuncture-Moxibustion and Tuina, Chengdu University of Traditional Chinese MedicineSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese MedicineSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese MedicineSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese MedicineWest China Hospital, Sichuan UniversityXiyuan Hospital, China Academy of Traditional Chinese MedicineNorthern Ireland Clinical Trials Unit and Methodology Hub, Centre for Public Health, Queen’s University BelfastSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese MedicineAbstract Background The World Health Organization declared on March 11, 2020, that the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has escalated from epidemic into pandemic. As the initial outbreak area, China has taken multiple active measures to deal with the epidemic. Updated versions of diagnosis and treatment guideline for novel coronavirus (COVID-19) patients have been issued, and traditional Chinese herbal medicine has been recommended as a treatment. The objective of this study will be to summarize the recommendations in current clinical practice guidelines about the use of traditional Chinese herbal medicine for COVID-19 patients. We will also evaluate and report on the methodological and reporting quality of these guidelines. Methods In this systematic review, we will search for guidelines, expert consensuses, and policy documents published since December 2019 in electronic databases (e.g., PubMed, EMBASE, and Chinese databases) and on websites of governments or organizations (e.g., The National Guideline Clearinghouse [NGC], Guidelines International Network [GIN], National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network [SIGN], and WHO). Eligible documents will be independently selected, and relevant data will be independently extracted by two reviewers. We will also independently evaluate the methodological quality and reporting quality of the included guidelines, using the Appraisal of Guidelines for REsearch & Evaluation (AGREE) II tool and Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement, respectively. Any discrepancies will be discussed and resolved through discussion among the reviewers. We will use the extracted information to summarize their recommendations for traditional Chinese herbal formulae and Chinese patent medicine for COVID-19 patients and to summarize the strength and quality of these recommendations with reference to the results of AGREE II and RIGHT tools. Discussion This review will summarize the recommendations in current clinical practice guidelines and provide insight into the implementation strategies for traditional Chinese herbal medicine in COVID-19 patients. Systematic review registration PROSPERO CRD42020179205http://link.springer.com/article/10.1186/s13643-020-01432-4COVID-19CoronavirusPneumoniaTraditional Chinese herbal medicineGuidelineSystematic review |
| spellingShingle | Yuxi Li Juan Li Dongling Zhong Yue Zhang Yonggang Zhang Yan Guo Mike Clarke Rongjiang Jin Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review Systematic Reviews COVID-19 Coronavirus Pneumonia Traditional Chinese herbal medicine Guideline Systematic review |
| title | Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review |
| title_full | Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review |
| title_fullStr | Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review |
| title_full_unstemmed | Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review |
| title_short | Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review |
| title_sort | clinical practice guidelines and experts consensuses of traditional chinese herbal medicine for novel coronavirus covid 19 protocol of a systematic review |
| topic | COVID-19 Coronavirus Pneumonia Traditional Chinese herbal medicine Guideline Systematic review |
| url | http://link.springer.com/article/10.1186/s13643-020-01432-4 |
| work_keys_str_mv | AT yuxili clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT juanli clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT donglingzhong clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT yuezhang clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT yonggangzhang clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT yanguo clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT mikeclarke clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview AT rongjiangjin clinicalpracticeguidelinesandexpertsconsensusesoftraditionalchineseherbalmedicinefornovelcoronaviruscovid19protocolofasystematicreview |